Asm Videos

Magazine hebdomadaire de l'ASM Clermont Auvergne du 21/11.09Author: asm Tags: ASM Clermont Auvergne Biarritz Olympique rugby Top14 Posted: 20 November 2009 Rating: 0.0 Votes: 0

le dernier tour d'honneur des joueurs du TFC de la saison Author: seb-31200 Tags: tfc stadium fête tennis folie gignac tolosa toulouse supporters ultras zidane FFF paris RCL rugby foot basket football france msn sport humour comique indians sharks31 PSG bordeaux lyon marseille asm Posted: 14 November 2009 Rating: 0.0 Votes: 0

Episode 2 du buzz de l'ASM Clermont AuvergneAuthor: asm Tags: ASM Clermont Auvergne rugby jaune bleu Posted: 13 November 2009 Rating: 0.0 Votes: 0

Author: bean63 Tags: asm montferrand clermont auvergne asmca ultrasvulcans rugby top14 stade marcel michelin ambiance tifo supporters toulouse Posted: 10 November 2009 Rating: 0.0 Votes: 0

Author: bean63 Tags: asm montferrand clermont auvergne asmca ultrasvulcans rugby top14 stade marcel michelin ambiance tifo supporters racing metro Posted: 10 November 2009 Rating: 0.0 Votes: 0

Author: bean63 Tags: asm montferrand clermont auvergne asmca ultrasvulcans rugby top14 stade marcel michelin ambiance tifo supporters racing metro Posted: 10 November 2009 Rating: 0.0 Votes: 0

Author: PauLineeexBordel Tags: ASM Viadana Rugby cup orange noir ballon jaune bleu Posted: 10 November 2009 Rating: 0.0 Votes: 0

Quand Chabal a été remplacé ^^Author: PauLineeexBordel Tags: ASM Racing metro rugby jaune bleu blanc chabal sebastien Posted: 10 November 2009 Rating: 0.0 Votes: 0

Author: bean63 Tags: asm montferrand clermont auvergne asmca ultrasvulcans rugby top14 stade marcel michelin ambiance tifo supporters csbj bourgoin pierre rajon Posted: 08 November 2009 Rating: 0.0 Votes: 0

Author: bean63 Tags: asm montferrand clermont auvergne asmca ultrasvulcans rugby top14 stade marcel michelin ambiance tifo supporters csbj bourgoin pierre rajon Posted: 08 November 2009 Rating: 0.0 Votes: 0

Parents are often presented with conflicting messages about germs and cleanliness. On the one hand, the news headlines warn us about dangerous "superbugs." On the other hand, there is growing concern that over-cleaning and excessive hygiene may weaken children's immune systems. Fortunately, there is real, vetted science available to help us understand how to best protect, without overprotecting, our kids. In episode 26 of MicrobeWorld Video, we talk with Dr. Harley Rotbart, author of Germ Proof Your Kids: The Complete Guide to Protecting (without Overprotecting) Your Family from Infections. Dr. Rotbart, a pediatric infectious diseases specialist at The University of Colorado and The Children's Hospital of Denver, has practiced, researched, and taught germ defense for the past 25 years. His new book serves as a resource for parents and health care providers to help put science back into the discussion of protecting kids from microscopic dangers. In addition to evaluating the traditional approaches to infection prevention (vaccines, antibiotics, etc.), Dr. Rotbart also analyzes the science behind Mom's advice about the effects of hygiene, nutrition, sleep, stress, exercise, and even wearing boots in the rain. It turns out Mom was right most of the time. This video was filmed live at the Marian Koshland Science Museum in Washington, D.C. and in various locations around the DC metro area. For more audio and video podcasts about microbiology, health and life science-related subjects, please visit www.microbeworld.org. If you would like to know more about Germ Proof Your Kids please visit www.germproofyourkids.com.

What kinds of bacteria are growing in your sink or your refrigerator? How about on your keyboard at work? Does soap really reduce the amount of bacteria on your hands? Dr. Keith Lampel of the Food and Drug Administration helps citizen scientists discover the world of bacteria in and around us. Filmed at the Marian Koshland Science Museum in Washington, D.C., this two-part science lab kicked off with a hands-on activity in the museum to observe the invisible bacteria that are present all around us. Attendees were shown how to prepare samples in the museum and took lab supplies with them for further investigation in their homes, offices and schools. For the second part of program, participants shared their scientific endeavors from the previous week as Dr. Lampel answered their questions and discussed recent research at the FDA, new technologies, and new initiatives in food safety. Dr. Keith Lampel is the Director of the Division of Microbiology within the Center for Food Safety and Applied Nutrition at the Food and Drug Administration (FDA). His research interests include the development of rapid detection methods for food-borne pathogens using DNA-based technology, and identifying the genes in these bacteria that are involved in the development of disease.

In the final episode of this 3 part video series on how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens, Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, goes in depth on the use of antimicrobial drugs in agriculture, their efficacy, and adverse human health consequences. Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine, discusses policy, regulatory and funding issues around antibiotic resistance. Both Dr. Tollefson and Dr. Levy take a handful of questions from the audience. The series, "Antibiotics: Is a Strong Offense the Best Defense?" was filmed on September 18, 2008 at the Koshland Science Museum in Washington, D.C. Parts 1 and 2 can be found at www.microbeworld.org.

On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 2 of this 3 part video series, Dr. Levy discusses how antibiotic resistance develops, the development practices drug companies employ when producing antimicrobials, and how this process may change in the future. Dr. Tollefson outlines how the FDA is encouraging the development of antibiotics in an industry that is mostly focussed on manufacturing drugs for chronic illnesses. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention. Part 3 will be published next week. To view part one visit the MicrobeWorld Video archives at www.microbeworld.org/look/MicrobeWorldVideo.aspx

Will we become defenseless against bacteria? Will bacteria always find a way to infect and even kill us? The emergence of antibiotic resistant strains of bacteria poses an enormous problem around the world. Scientists believe that the overuse of antibiotics is increasing the appearance of these pathogens. In the US, increasing casualties resulting from drug resistant staphylococcus infections received wide media attention. While antibiotics only work on bacterial infections, many patients and doctors regard antibiotics as a front-line form of treating any type of infection. Antibiotics are often prescribed because the specific pathogen that is causing an illness is often difficult to determine. In some cases they are used as a preventative measure. But is this the best defense? Are there ways to beat bacteria at their own game? On September 18, 2008 at the Koshland Science Museum in Washington, D.C., Dr. Stuart Levy, professor of Molecular Biology and Microbiology at Tufts University School of Medicine and Dr. Linda Tollefson, Assistant Commissioner for Science at the U.S. Food and Drug Administration, discussed how to optimize antibiotic use and how to minimize the emergence of drug resistant pathogens. In part 1 of this 3 part video series, Dr. Levy discusses the basics of microbial pathogens, bacteria, and antibiotic resistance. And, Dr. Tollefson outlines the various types and classes of antibiotic drugs, approved uses, and current levels of effectiveness. Dr. Levy is Professor of Molecular Biology and Microbiology at Tufts University School of Medicine where he is the Director of the Center for Adaptation Genetics and Drug Resistance. He directs research on mechanisms of bacterial antibiotic resistance. Stuart Levy is also Staff Physician at the Tufts Medical Center and he also serves as the president of The International Alliance for the Prudent Use of Antibiotics. Dr. Tollefson is Assistant Commissioner for Science at the U.S. Food and Drug Administration (FDA). She previously served as Deputy Director of the Center for Veterinary Medicine (CVM), where she led CVM's efforts to implement a risk-based approach to address antimicrobial resistance, fulfilling a 2001 Congressional mandate, and was instrumental in the founding of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. Tollefson also served as Chief of Epidemiology in the Center for Food Safety and Applied Nutrition where she successfully investigated numerous outbreaks of food borne disease and served as liaison to the Centers for Disease Control and Prevention. Parts 2 and 3 will be published over the coming weeks.

West Nile virus entered the United States in 1999 and is now considered a seasonal epidemic that starts in the summer and continues into the fall. First isolated in Uganda in 1937, the virus can cause severe human meningitis or encephalitis in 1% of those infected. In 2007 the U.S. Centers for Disease Control reported 124 fatalities. The rapid spread of West Nile virus has put local and state mosquito surveillance programs on the front line of public health and disease preparedness. In this episode, MicrobeWorld Video interviews Dr. Jorge Arias, an expert in vector-borne diseases of the Americas. Arias currently serves as the Environmental Health Supervisor of the Fairfax County Health Department in Northern Virginia. In this role, he is responsible for directing the Disease-Carrying Insects Program which focuses on West Nile virus and Lyme disease. For more information about West Nile Virus, please visit: U.S. Centers for Disease Control and Prevention - http://www.cdc.gov/ncidod/dvbid/westnile/index.htm National Pesticide Information Center - http://npic.orst.edu/wnv/ Fairfax County Health Department - http://www.fairfaxcounty.gov/hd/westnile/ This episode was filmed at the Marian Koshland Science Museum, the Fairfax County Health Department, Huntley Meadows Park in Fairfax, Va., and the National Zoo in Washington, D.C.

MicrobeWorld Video 14 HIV/AIDS Education In this episode of MicrobeWorld Video we ask some leading researchers, education specialists, and public health officials about the state of HIV/AIDS education in America and ideas they have to support the teaching of microbial evolution using the latest HIV/AIDS research all while instilling innovative prevention strategies. Filmed at a forum for educators on February, 11, 2008 at the Koshland Science Museum in Washington, D.C. and at San Diego State University, this episode features the following experts: Roland Wolkowicz, Ph.D., Assistant Professor, Department of Biology, San Diego State University, whose research focus is on the use of random peptide libraries and other chemical genetics approaches for the study of viral pathogenesis and the search of antiviral factors in HIV1 and HCV. Shannon Lee Hader, M.D., MPH, Director of the HIV/AIDS Administration for Washington, D.C., an epidemiologist and public health physician who has worked with HIV-infected children and adults in Brazil, Jamaica, and Zimbabwe. Anila Asghar, Ph.D., Assistant Professor of Education at Johns Hopkins University, whose research focuses on curriculum development and evolution. Educational resources mentioned within the video can be found online at: Koshland Science Museum http://koshlandscience.org/teachers/webquest.jsp NIH Curriculum Guide http://science.education.nih.gov/supplements/nih1/Diseases/default.htm Howard Hughes MedicalInstitute http://www.hhmi.org/biointeractive/ Please feel free to embed or distribute this video.

Since the introduction of MSX and Dermo in the 1950 s, two infectious diseases that played a large role in the decline the Chesapeake Bay s oyster population, several oyster hatcheries along the Eastern seaboard are working with scientists across many fields to develop innovative restoration programs. One idea is to introduce a non-native oyster from China called Crassostrea ariakensis. In this video podcast, MicrobeWorld talks about current research underway with C. ariakensis, the potential risk of new diseases that could affect the Bay s ecology and/or human health, the attitudes of Maryland s watermen toward the oysters possible introduction, and the role of local, state and federal policy. Special thanks goes out to the DC Science Writers Association, the Marian Koshland Science Museum and the University of Maryland Center for Environmental Science s Horn Point Laboratory for helping with the logistics and planning of the shoot.